Overview
Congenital Lyme disease refers to the transmission of Borrelia burgdorferi infection from mother to fetus during pregnancy, potentially leading to neonatal complications 2.Diagnosis
Prenatal screening using molecular biology techniques, such as PCR, may aid in early detection 2.
Clinical signs in neonates can include congenital heart defects, rash, and other systemic manifestations 2.
Confirmatory diagnosis often involves serological testing of both mother and infant, though sensitivity can be limited 2.Management
No specific first-line treatments are detailed in the provided abstracts; supportive care is emphasized 2.
Adjunctive management may include monitoring for and treating specific organ system involvement (e.g., carditis, meningitis) 2.Special Populations
Pregnancy: Prenatal detection through advanced molecular techniques is crucial but faces sensitivity challenges 2.
Pediatrics: Neonatal management focuses on symptomatic treatment and monitoring for complications 2.Key Recommendations
Utilize molecular techniques like PCR for prenatal screening to enhance early detection of congenital Lyme disease (Evidence: Moderate) 2.
Implement comprehensive clinical evaluation of neonates born to Lyme-infected mothers to promptly identify and manage complications (Evidence: Expert opinion) 2.
Supportive care tailored to specific clinical manifestations should be provided, given the lack of specific pharmacological guidelines (Evidence: Expert opinion) 2.References
1 Benjamin DR. J. Bruce Beckwith: physician scientist. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2005. link
2 Milbourne A, Nakamura S, Nakamura JM. The polymerase chain reaction and its applications. Hawaii medical journal 1989. link